| MITDX | VITSX | MITDX / VITSX | |
| Total Expense Ratio | 0.45 | 0.03 | 1,500% |
| Annual Report Gross Expense Ratio | 0.45 | 0.03 | 1,500% |
| Fund Existence | 21 years | 28 years | - |
| Gain YTD | 11.885 | 15.987 | 74% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.84B | 2.05T | 0% |
| Annual Yield % from dividends | 0.74 | 1.12 | 66% |
| Returns for 1 year | -3.43 | 13.43 | -26% |
| Returns for 3 years | 18.12 | 68.26 | 27% |
| Returns for 5 years | 17.98 | 84.03 | 21% |
| Returns for 10 years | 56.77 | 236.10 | 24% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EPLCX | 23.78 | 0.13 | +0.55% |
| NYLI Epoch U.S. Equity Yield Class I | |||
| IRTCX | 28.76 | 0.10 | +0.35% |
| Invesco Dividend Income R | |||
| SCJAX | 8.21 | 0.01 | +0.12% |
| Steward Covered Call Income A | |||
| UEMPX | 10.53 | 0.01 | +0.10% |
| UBS Emerging Markets Equity Opp P | |||
| PACLX | 38.35 | 0.02 | +0.05% |
| T. Rowe Price Capital Appreciation Adv | |||